Palbociclib plus exemestane with GnRH agonist vs capecitabine in premenopausal patients with HR+/HER2-metastatic breast cancer: Updated survival results of the randomized phase 2 study Young-PEARL.

  • Park, Yeon Hee; 
  • Lee, Kyung-Hun; 
  • Kim, Gun Min; 
  • Kang, Seok Yun; 
  • Lee, Keun Seok; 
  • ... Lee, Moon Hee; 
  • 외 14명
Citations

WEB OF SCIENCE

2

키워드

283-217; 261-492-2769; 261-436-7559-2760; 261-492-3532-2373; 3282-4644-7627-3745-10025; 261-492-3532-2370-7650-2700; 3282-3306-4614-3760; 5; 4; 4; 3; 3; 3; 2; 81; 92; 236; 81; 236; 92; 312; 12; 12; 5; 3; 3; 3; 1
제목
Palbociclib plus exemestane with GnRH agonist vs capecitabine in premenopausal patients with HR+/HER2-metastatic breast cancer: Updated survival results of the randomized phase 2 study Young-PEARL.
저자
Park, Yeon Hee; Lee, Kyung-Hun; Kim, Gun Min; Kang, Seok Yun; Lee, Keun Seok; Kim, Jee Hyun; Lee, Kyoung Eun; Ahn, Hee Kyung; Lee, Moon Hee; Kim, Hee Jun; Kim, Hanjo; Koh, Su-Jin; Kim, Ji-Yeon; Sohn, Joohyuk; Kim, Sung-Bae; Ahn, Jin Seok; Kim, Seonwoo; Cho, Hyun; Jung, Kyung Hae; Im, Seock-Ah
DOI
10.1200/JCO.2024.42.17_suppl.LBA1002
발행일
2024-06-10
유형
Meeting Abstract
저널명
Journal of Clinical Oncology
권
42
호
17_SUPPL
페이지
LBA1002 ~ LBA1002